Descovy 25 mg

Descovy 25 mg tablets contain tenofovir alafenamide, a medication used to manage certain viral infections. This oral tablet is designed for convenient daily use and is manufactured by Gilead Sciences Canada Inc.

Descovy 25 mg tablets are primarily used in the treatment of chronic hepatitis B virus (HBV) infection. This medication works by reducing the amount of virus in the body, helping to manage the condition over time. Descovy is often prescribed as part of a comprehensive treatment plan for HBV.

Common effects of Descovy 25 mg tablets may include mild gastrointestinal discomfort, headaches, and fatigue. Some individuals may also experience dizziness or nausea. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Descovy 25 mg tablets should be handled with care, stored in a cool, dry place, and kept out of reach of children. It is important to follow the prescribed dosage and not to share this medication with others. Individuals with known allergies to tenofovir alafenamide should avoid using this medication.

Descovy 25 mg tablets may interact with other medications, including certain antiviral drugs and medications that affect kidney function. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.